Prevalence and Related Risk Factors Associated with Coronary Heart Disease (CHD) Among Middle-Aged and Elderly Patients with Vision Impairment (VI)

References

• Disability LGotSCNSSo, China NBoSotPsRo. Communiqué on major statistics of the second china national sample survey on disability. China J Rehabil Theor Pract. 2006;12(12):1013.
   Google Scholar
• Hsueh CM, Wey JH, Yeh JS, Wu CH, Liou TH, Chang KH. Incidence and risk of major heart diseases in middle-aged adults with moderate to severe vision impairment: a Population-Based Cohort Study. Br J Ophthalmol. 2019;103(8):1054–1059. doi:10.1136/bjophthalmol-2018-312471
   PubMed Web of Science ®Google Scholar
• Fong JH. Disability incidence and functional decline among older adults with major chronic diseases. BMC Geriatr. 2019;19(1):323. doi:10.1186/s12877-019-1348-z
   PubMed Web of Science ®Google Scholar
• Park SJ, Ahn S, Woo SJ, Park KH. Extent of exacerbation of chronic health conditions by visual impairment in terms of health-related quality of life. JAMA Ophthalmol. 2015;133(11):1267–1275. doi:10.1001/jamaophthalmol.2015.3055
   PubMed Web of Science ®Google Scholar
• VanNasdale DA, Jones-Jordan LA. Multi-state assessment of vision impairment and associated morbidity. Invest Ophthalmol Vis Sci. 2017;58(8):2202.
   Web of Science ®Google Scholar
• Crews JE, Chou CF, Sekar S, Saaddine JB. The prevalence of chronic conditions and poor health among people with and without vision impairment, aged ≥65 years, 2010–2014. Am J Ophthalmol. 2017;182:18–30. doi:10.1016/j.ajo.2017.06.038
   PubMed Web of Science ®Google Scholar
• Park SJ, Ahn S, Park KH. Burden of visual impairment and chronic diseases. JAMA Ophthalmol. 2016;134(7):778–784. doi:10.1001/jamaophthalmol.2016.1158
   PubMed Web of Science ®Google Scholar
• Siantar RG, Cheng CY, Gemmy Cheung CM, et al. Impact of visual impairment and eye diseases on mortality: the Singapore Malay Eye Study (SiMES). Sci Rep. 2015;5(1):16304. doi:10.1038/srep16304
   PubMed Web of Science ®Google Scholar
• McGuire S. Centers for disease control and prevention. state indicator report on physical activity, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014. Adv Nutr. 2014;5(6):762–763. doi:10.3945/an.114.007211
   PubMed Web of Science ®Google Scholar
• Liu S, Li Y, Zeng X, et al. Burden of cardiovascular diseases in China, 1990–2016: findings from the 2016 Global Burden of Disease Study. JAMA Cardiol. 2019;4(4):342–352. doi:10.1001/jamacardio.2019.0295
   PubMed Web of Science ®Google Scholar
• Khamis RY, Ammari T, Mikhail GW. Gender differences in coronary heart disease. Heart. 2016;102(14):1142–1149. doi:10.1136/heartjnl-2014-306463
   PubMed Web of Science ®Google Scholar
• Steinberger J, Daniels SR, Hagberg N, et al. Cardiovascular health promotion in children: challenges and opportunities for 2020 and beyond: a scientific statement from the American heart association. Circulation. 2016;134(12):e236–55. doi:10.1161/cir.0000000000000441
   PubMed Web of Science ®Google Scholar
• Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203–212. doi:10.1038/s41569-018-0119-4
   PubMed Web of Science ®Google Scholar
• Hollar DW Jr, Lewis JS. Heart age differentials and general cardiovascular risk profiles for persons with varying disabilities: NHANES 2001–2010. Disabil Health J. 2015;8(1):51–60. doi:10.1016/j.dhjo.2014.07.007
   PubMed Web of Science ®Google Scholar
• Liljas AE, Wannamethee SG, Whincup PH, et al. Socio-demographic characteristics, lifestyle factors and burden of morbidity associated with self-reported hearing and vision impairments in older British community-dwelling men: a Cross-Sectional Study. J Public Health (Oxf). 2016;38(2):e21–8. doi:10.1093/pubmed/fdv095
   PubMed Web of Science ®Google Scholar
• Physical Activity Guidelines Advisory Committee.Physical Activity Guidelines Advisory Committee Report,2008. Washington,DC: US Department of Health and Human Services;2008 
   Google Scholar
• Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–381. doi:10.1249/00005768-198205000-00012
   PubMed Web of Science ®Google Scholar
• Unger T, Borghi C, Charchar F, et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–1357. doi:10.1161/hypertensionaha.120.15026
   PubMed Web of Science ®Google Scholar
• World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. 2006.
   Google Scholar
• Jun-Ren ZH, Run-Lin GA, Shui-Ping ZH, Guo-Ping LU, Dong ZH, Jian-Jun LI. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol. 2018;15(1):1–29. doi:10.11909/j.issn.1671-5411.2018.01.011
   PubMedGoogle Scholar
• Wilcox T, Newman JD, Maldonado TS, Rockman C, Berger JS. Peripheral vascular disease risk in diabetic individuals without coronary heart disease. Atherosclerosis. 2018;275:419–425. doi:10.1016/j.atherosclerosis.2018.04.026
   PubMed Web of Science ®Google Scholar
• Rennie TW, Roberts W. Data mining of tuberculosis patient data using multiple correspondence analysis. Epidemiol Infect. 2009;137(12):1699–1704. doi:10.1017/s0950268809002787
   PubMed Web of Science ®Google Scholar
• Li YH, Chen JW, Lin TH, et al. A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan. J Formos Med Assoc. 2020;119(3):674–684. doi:10.1016/j.jfma.2019.04.007
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-Control Study. Lancet. 2004;364(9438):937–952. doi:10.1016/s0140-6736(04)17018-9
   PubMed Web of Science ®Google Scholar
• Kołtuniuk A, Rosińczuk J. The prevalence of risk factors for cardiovascular diseases among Polish surgical patients over 65 years. Clin Interv Aging. 2016;11:631–639. doi:10.2147/cia.S105201
   PubMed Web of Science ®Google Scholar
• Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet. 2014;383(9921):970–983. doi:10.1016/s0140-6736(13)61836-x
   PubMed Web of Science ®Google Scholar
• Fenwick EK, Cheng GH, Man REK, et al. Inter-relationship between visual symptoms, activity limitation and psychological functioning in patients with diabetic retinopathy. Br J Ophthalmol. 2018;102(7):948–953. doi:10.1136/bjophthalmol-2017-310915
   PubMed Web of Science ®Google Scholar
• Ramos AR, Wallace DM, Williams NJ, et al. Association between visual impairment and sleep duration: analysis of the 2009 National Health Interview Survey (NHIS). BMC Ophthalmol. 2014;14(1):115. doi:10.1186/1471-2415-14-115
   PubMed Web of Science ®Google Scholar
• Kim KN, Park SJ, Kim W, et al. Modification of the association between visual impairment and mortality by physical activity: a Cohort Study among the Korean national health examinees. Int J Environ Res Public Health. 2019;16(22):4386. doi:10.3390/ijerph16224386
   PubMed Web of Science ®Google Scholar
• Phoenix C, Griffin M, Smith B. Physical activity among older people with sight loss: a Qualitative Research Study to inform policy and practice. Public Health. 2015;129(2):124–130. doi:10.1016/j.puhe.2014.10.001
   PubMed Web of Science ®Google Scholar
• Capella-McDonnall M. The Need for Health Promotion for Adults Who Are Visually Impaired. J Vis Impair Blind. 2007;101(3):133–145. doi:10.1177/0145482X0710100302
   Web of Science ®Google Scholar
• Smith L, Timmis MA, Pardhan S, Latham K, Johnstone J, Hamer M. Physical inactivity in relation to self-rated eyesight: cross-sectional analysis from the English Longitudinal Study of Ageing. BMJ Open Ophthalmol. 2017;1(1):e000046. doi:10.1136/bmjophth-2016-000046
   PubMed Web of Science ®Google Scholar
• Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R. Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med. 2014;371(12):1091–1099. doi:10.1056/NEJMoa1406430
   PubMed Web of Science ®Google Scholar
• Ferrari R, Fox K. Heart rate reduction in coronary artery disease and heart failure. Nat Rev Cardiol. 2016;13(8):493–501. doi:10.1038/nrcardio.2016.84
   PubMed Web of Science ®Google Scholar